SciELO - Scientific Electronic Library Online

vol.103 issue6Prevalence of Dyslipidemia According to the Nutritional Status in a Representative Sample of São PauloComparison of Cardiovascular Risk Factors in Different Areas of Health Care Over a 20-Year Period author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Arquivos Brasileiros de Cardiologia

Print version ISSN 0066-782X

Arq. Bras. Cardiol. vol.103 no.6 São Paulo Dec. 2014  Epub Oct 14, 2014 

Original Articles

Impact of Atrial Fibrillation Ablation on Left Ventricular Filling Pressure and Left Atrial Remodeling

Simone Nascimento dos Santos1  2 

Benhur Davi Henz1 

André Rodrigues Zanatta1 

José Roberto Barreto1 

Kelly Bianca Loureiro1 

Clarissa Novakoski1 

Marcus Vinícius Nascimento dos Santos1 

Fabio F. Giuseppin1 

Edna Maria Oliveira1 

Luiz Roberto Leite1 

1Instituto Brasília de Arritmia- Universidade de Brasília, DF - Brazil

2Faculdade de Medicina (UnB), Brasília, DF - Brazil



Left ventricular (LV) diastolic dysfunction is associated with new-onset atrial fibrillation (AF), and the estimation of elevated LV filling pressures by E/e' ratio is related to worse outcomes in patients with AF. However, it is unknown if restoring sinus rhythm reverses this process.


To evaluate the impact of AF ablation on estimated LV filling pressure.


A total of 141 patients underwent radiofrequency (RF) ablation to treat drug-refractory AF. Transthoracic echocardiography was performed 30 days before and 12 months after ablation. LV functional parameters, left atrial volume index (LAVind), and transmitral pulsed and mitral annulus tissue Doppler (e' and E/e') were assessed. Paroxysmal AF was present in 18 patients, persistent AF was present in 102 patients, and long-standing persistent AF in 21 patients. Follow-up included electrocardiographic examination and 24-h Holter monitoring at 3, 6, and 12 months after ablation.


One hundred seventeen patients (82.9%) were free of AF during the follow-up (average, 18 ± 5 months). LAVind reduced in the successful group (30.2 mL/m2 ± 10.6 mL/m2 to 22.6 mL/m2 ± 1.1 mL/m2, p < 0.001) compared to the non-successful group (37.7 mL/m2 ± 14.3 mL/m2 to 37.5 mL/m2 ± 14.5 mL/m2, p = ns). Improvement of LV filling pressure assessed by a reduction in the E/e' ratio was observed only after successful ablation (11.5 ± 4.5 vs. 7.1 ± 3.7, p < 0.001) but not in patients with recurrent AF (12.7 ± 4.4 vs. 12 ± 3.3, p = ns). The success rate was lower in the long-standing persistent AF patient group (57% vs. 87%, p = 0.001).


Successful AF ablation is associated with LA reverse remodeling and an improvement in LV filling pressure.

Key words: Atrial Fibrillation; Atrial Remodeling; Catheter Ablation; Echocardiography; Stroke Volume; Ventricular Function



A disfunção diastólica do ventrículo esquerdo (VE) está associada a novos episódios de fibrilação atrial (FA), e a estimativa das pressões de enchimento do VE através da razão E/e' está relacionada a um pior prognóstico em pacientes com FA. Entretanto, não se sabe se a restauração do ritmo sinusal pode reverter este processo.


Avaliar o impacto da ablação da FA na estimativa da pressão de enchimento do VE.


Um total de 141 pacientes foi submetido à ablação por radiofrequência (RF) para o tratamento da FA refratária a drogas. Foi realizado ecocardiograma transtorácico 30 dias antes e 12 meses após a ablação. Foram avaliados os parâmetros funcionais do VE, volume do átrio esquerdo indexado (VAEi) e Doppler transmitral pulsado e Doppler tecidual do anel mitral (e' e E/e'). Dezoito pacientes apresentavam FA paroxística, 102 persistente e 21 pacientes FA persistente de longa duração. O acompanhamento incluiu ECG e monitoramento pelo sistema Holter 24h, 3, 6 e 12 meses após a ablação.


Cento e dezessete pacientes (82,9%) não apresentaram FA durante o acompanhamento (média de 18 meses ± 5 meses). O VAEi apresentou redução significativa no grupo com sucesso (30,2 mL/m2 ± 10,6 mL/m2 para 22,6 mL/m2 ± 1,1 mL/m2, p < 0,001) em comparação ao grupo sem sucesso (37,7 mL/m2 ± 14,3 mL/m2 para 37,5 mL/m2 ± 14,5 mL/m2, p = ns). A melhora da estimativa da pressão de enchimento do VE, avaliada através da redução na razão E/e', foi observada apenas após ablação com sucesso (11,5 ± 4,5 vs. 7,1 ± 3,7, p < 0,001), não sendo observada em pacientes com FA recorrente (12,7 ± 4,4 vs. 12 ± 3,3, p = ns). A taxa de sucesso foi menor no grupo com FA persistente de longa duração (57% vs. 87%, p = 0,001).


A ablação da FA com sucesso está associada ao remodelamento reverso do átrio esquerdo (AE) e a uma melhora da estimativa na pressão de enchimento do VE.

Palavras-Chave: Fibrilação Atrial; Remodelamento Atrial; Ablação por Cateter; Ecocardiografia; Débito Cardíaco; Função Ventricular


Grade I diastolic dysfunction is often considered a normal finding in the elderly, but it was found to be an independent predictor of atrial fibrillation (AF)1. Diastolic dysfunction contributes to the occurrence of AF because left ventricular (LV) relaxation abnormalities lead to a reduction in passive left atrial (LA) emptying, an increase in LA volume and pressure, and pulmonary vein (PV) distension, resulting in electrical remodeling2-4. It is not known if the occurrence of AF would worsen or even lead to increased LV filling pressure. The ratio of early diastolic mitral inflow velocity (E) and early diastolic mitral annular velocity (e'), E/e', is useful in the estimation of LV filling pressure5-9.

Catheter ablation has emerged as the most promising strategy for treating AF10-13. Because restoring sinus rhythm is associated with both LA reverse remodeling and the improvement in LA function14-16, we hypothesize that successful AF ablation would improve LV filling pressure. This study sought to evaluate the impact of AF ablation on LV filling pressure, estimated by E/e' ratio.


Patient population

In this study, we prospectively included consecutive patients with symptomatic, drug-refractory AF referred for ablation to the Instituto Brasília de Arritmia, between January 2007 and July 2010. Patients with paroxysmal, persistent, or long-standing persistent AF were classified according to AHA/ACC/ESC/HRS guidelines17. Exclusion criteria were as follows: significant cardiac valvular disease, first episode of AF, LA thrombus or tumors, hyperthyroidism, angina, or myocardial infarction occurring less than six months prior to ablation, or contraindications to warfarin use. Patients with previous percutaneous or surgical ablation procedures for AF were also excluded. Anticoagulation therapy with warfarin was used for at least one month pre-ablation and at least four months post-ablation in all patients, including those patients with paroxysmal AF. Seventy-three percent of patients were taking an angiotensin-I converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) during baseline and follow-up echocardiography. There was no important change in medication profile during the study period, except for the withdrawal of anticoagulation therapy for successful ablation patients with low risk (CHADS 2 ≤ 1) for embolic events.

Transesophageal echocardiography (TEE) was performed within 24 h of ablation to exclude LA thrombus. Approval for this study was obtained from the local ethics committee, and written informed consent was obtained from all patients.

EP study and ablation technique

A multi-polar catheter was inserted into the coronary sinus from the jugular vein for recording and stimulation. Before the first transseptal puncture, 3,000 IU intravenous heparin was given, and additional heparin was administered to keep the activated coagulation time > 350 sec18. After transseptal access, a circular mapping catheter was used to guide the isolation of all four pulmonary veins (PVs). Ablation was performed using either 8-mm non-irrigated tip (35 W, 50 ºC) or 3.5-mm irrigated tip catheter (25 - 30 W, 42 ºC) to achieve PV antrum isolation. The ablation end-point was the elimination of all PV potentials. Additional linear lesions were performed in long-standing persistent AF as previously reported18. Ablation was performed in the antral region of all pulmonary veins (PV) guided by the presence of PV potentials on the circular mapping catheter with the aim of achieving pulmonary vein isolation. Additional LA substrate modification was performed at the discretion of the operator, mostly for patients with long-standing persistent AF, which included roof line, mitral isthmus line, coronary sinus ablation, and CFAE at the discretion of the operator. Briefly, CFAE was defined as continuous or multicomponent electrograms recorded during atrial fibrillation. Reinduction of AF was not tried after ablation.

If any left atrial tachycardia was induced, the entrainment mapping technique was used to identify critical areas for the reentrant circuit. In patients with documented typical atrial flutter, additional cavotricuspid isthmus ablation was performed.

Intracardiac echocardiography (ICE) was used to guide transseptal puncture and ablation using Sequoia(tm) or Cypress(tm) ultrasound systems (Siemens Medical Solutions USA Inc., Ultrasound Division, Mountain View, CA) and a deflectable, 5.5 - 10 MHz, phased-array AcuNav(tm) catheter (Siemens Medical Solutions USA, Inc.) with pulsed-wave Doppler. ICE images were also used to avoid ablation inside PVs or the LA appendage. Beginning in January 2007, ICEs were also used to guide visualization of the esophagus.

Transthoracic echocardiography (TTE)

TTE was performed at 30 days before and 12 months after AF ablation using a Sequoia(tm) ultrasound system (Siemens Medical Solutions USA, Inc.). The following data were measured: LV diameter and volume, LVEF (left ventricular ejection fraction) and LV mass, LA diameter and volume, transmitral pulsed Doppler E and A waves, mean of septal and lateral mitral valve annulus spectral tissue Doppler (TDI) e' and a' wave, and mitral regurgitation quantification. LA volume was measured using Simpson's method as recommended by the American Society of Echocardiography, and then LA volume was indexed (LAind) by dividing by body surface area (reference value < 29 mL/m2)19. Because the mitral annulus TDI is less load-dependent and is more feasible to perform in AF patients, it was used to estimate LV filling pressure. Importantly, the LAVind and E/e' ratio could be consistently recorded during sinus rhythm or AF. Ninety-three patients (66%) were in AF during baseline echocardiographic measurements. In these patients, five measurements were averaged to calculate all data.


After the ablation procedure, anticoagulation therapy was maintained for at least four months, and antiarrhythmic drugs (AAD) were used for three months in all patients. During the first year of follow-up, ECG was recorded monthly, exercise testing in the sixth month, TTE was done in the twelfth month, and Holter monitoring was done in the third, sixth, and twelfth months after ablation. Recurrence was defined as symptomatic or asymptomatic AF recorded by ECG, exercise testing, or Holter monitoring, after a blanking period of three months. All patients were followed for at least one year.

Statistic analysis

Continuous variables are reported as mean ± standard deviation (SD), and compared with Student's t-test or ANOVA. Categorical variables are reported as percentages and compared with chi-square test or Fisher's exact test, as appropriate. A probability value < 0.05 was considered significant. Interobserver and intraobserver variability were calculated and expressed as percent average value. All statistical analysis was performed with SPSS® 16 for Mac.


Three patients were excluded for having moderate mitral regurgitation. The study population comprised 141 patients [mean age, 67 ± 11 years, 71 (50.3%) male]. Eighteen (12.8%) patients had paroxysmal AF, 102 (72.3%) patients had persistent AF, and 21 (14.9%) patients had long-standing persistent AF. The mean failed AAD trials per patient were 2.1 ± 0.7. One hundred and twenty-six patients (89.3%) underwent one procedure, nine patients (6.4%) underwent two procedures, and six patients (4.3%) underwent three procedures.

All patients were followed for at least one year. Over a mean follow-up period of 18 ± 5 months, 117 (82.9%) patients were in sinus rhythm, 70.1% were not, and 12.8% were on previously failed AAD therapy. Twenty-four (17.1%) patients failed AF ablation and were defined as the non-successful group.

Baseline Characteristics

Baseline characteristics are presented in Table 1. There were more NYHA class II patients (56.4% vs. 75%, p < 0.0001) and long-standing persistent AF patients (10.2 vs. 37.5%, p = 0.001) in the non-successful group. At baseline, patients with successful ablation showed lower LAVind (30.2 ± 10.6 mL/m2 vs. 37.7 ± 14.3 mL/m2, p = 0.023), E/e' ratio (11.5 ± 4.5 vs. 12.7 ± 4, p = 0.01), and E/A ratio (0.9 ± 0.3 vs. 1.15 ± 0.5, p < 0.0001) and higher LVEF (68.6 ± 4.9% vs. 63.5 ± 8.6%, p = 0.01) and e' velocity (8.1 ± 4.3 cm/s vs. 6.4 ± 1.8 cm/s, p = 0.009) than non-successful patients. There was no remarkable variation in patient's body surface area during the study period.

Table 1 Baseline characteristics in patients with successful and non-successful atrial fibrillation ablation 

Variable Successful Group (n=117) Non-successful (n=24) p
Gender, male, n (%) 61 (52.1%) 10 (41.7%) ns
Age (years) 68 ± 12 63 ± 9 ns
NYHA FC I 51 (43.5%) I 3 (12.5%) < 0.0001
II 66 (56.4 %) II 18 (75%)
  III 3 (12.5%)
AF type paroxysmal 18 (15.4%) paroxysmal 0 0.001
persistent 87 (74.4%) persistent 15 (62.4%)
Longstanding-Persistent 12 (10.2%) Longstanding-Persistent 9 (37.5%)
CAD 0 3 (2.6%) ns
Alcohol abuse 18 (15.4%) 3 (12.5%) ns
Chagas disease 9 (7.7%) 6 (25%) ns
Smoking 3 (2.6%) 3 (12.5%) ns
HBP 69 (59%) 18 (75%) ns
DM 6 (5.1%) 3 (12.5%) ns
CPOD 3 (2.6%) 0 ns
DD 61 (52.1%) 17 (52%) <0.01
LAV ind (mL/m2) 30.2 ± 10.6 37.7 ± 14.3 0.023
LVD (mm) 48.7 4.4 47.0 ± 1 ns
LVS (mm) 29.8 3.4 28.0 ± 2.5 ns
LV mass (g) 209.4 ± 49.8 186.2 ± 25.2 ns
LVEF (%) 68.6 4.9 63.5 ± 8.6 0.01
E/A ratioz 0.9 0.3 1.15 ± 0.05 < 0.0001
e' (cm/s) 8.1 4.3 6.4 ± 1.8 0.009
a' (cm/s) 10.1 0.4 9.0 ± 1.3 ns
E/e' ratio 11.5 4.5 12.7 ± 4.4 0.01

FC: functional class; NYHA: New York Heart Association; AF: atrial fibrillation; CAD: coronary artery disease; HBP: high blood pressure; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; DD: diastolic dysfunction; LAV ind: left atrial volume index; LVD: left ventricular diastole; LVS: left ventricular systole: LV: left ventricle; LVEF: left ventricular ejection fraction.


During follow-up, ablation was successful in a greater percentage of patients with paroxysmal and persistent AF than patients with long-standing persistent AF (87% vs. 57%, respectively, p = 0.001). Acute PV isolation was achieved in all patients in this cohort. Additional LA substrate modification was frequently performed in patients with non-paroxysmal AF (roof line: paroxysmal = 3 patients vs. non-paroxysmal = 35 patients, p = 0.001; mitral isthmus line: paroxysmal = 0 patients vs. non-paroxysmal = 54 patients, p < 0.001; coronary sinus ablation: paroxysmal = 0 patients vs. non-paroxysmal = 27 patients, p < 0.001; CFAE: paroxysmal = 1 patient, non-paroxysmal = 15 patients, p < 0.01). The average procedure time for the entire cohort was 265 ± 55 min (204 ± 51 min for paroxysmal AF, 277 ± 79 min for non-paroxysmal AF, p = 0.009).

In patients with successful ablation, there was a significant improvement in NYHA functional class compared to recurrent AF patients (p < 0.001) (Table 2). Furthermore, there was a significant reduction in parameters of LA reverse remodeling in successful patients (LAVind: 30.2 mL/m2 ± 10.6 mL/m2 vs. 22.6 mL/m2 ± 1.1 mL/m2, p < 0.001) (Figure 1). Also, in successful patients, LV filling pressure improved, as E/e' ratio was reduced significantly after ablation (11.5 ± 4.5 vs. 7.1 ± 3.7, p < 0.001, respectively). These observations were not seen in patients with recurrent AF. Analyzing only patients with paroxysmal AF, we also observed a reduction in LAVind (21.8 mL/m2 ± 11.9 mL/m2 to 14.1 mL/m2 ± 5.5 mL/m2, p < 0.001) and in the E/e' ratio (10.3 ± 3 vs. 5.0 ± 0.5, p < 0.001).

Table 2 Follow-up characteristics in patients with successful and non-successful atrial fibrillation ablation 

Variable Successful Group (n = 117) p Non-Successful (n = 24) p
  Pre-ablation Post-ablation   Pre-ablation Post-ablation  
NYHAFC 1.57 ± 0.5 1.1 ± 0.3 < 0.001 2.0 ± 0.5 2.0 ± 0.4 ns
LAV ind (ml/m2) 30.2 ± 10.6 22.6 ± 1.1 < 0.001 37.7 ± 14.3 37.5 ± 14.5 ns
LVD (mm) 49.0 ± 4.7 49.0 ± 5.1 ns 46.0 ± 0.1 49.0 ± 1.0 0.001
LVS (mm) 29.9 ± 3.6 29.4 ± 3.4 ns 27.0 ± 3.2 27.0 ± 2.1 ns
LV mass (g) 195.3 ± 44.5 192.4 ± 51.8 ns 173.5 ± 27.9 178.5 ± 21.3 ns
LVEF(%) 68.6 ± 4.9 70.0 ± 4.7 ns 63.5 ± 8.6 66.0 ± 3.2 ns
E/A ratio 0.9 ± 0.3 1.0 ± 0.3 ns 1.1 ± 0.05 1.5 ± 0.02 ns
e' (cm/s) 8.1 ± 4.3 9.5 ± 2.5 ns 6.4 ± 1.8 7.9 ± 0.5 ns
a' (cm/s) 10.1 ± 0.4 10.0 ± 0.2 ns 9.0 ± 1.3 8.7 ± 0.9 ns
E/e' ratio 11.5 ± 4.5 7.1 ± 3.7 < 0.001 12.7 ± 4 12.0 ± 3.3 ns
LAV ind (ml/m2) -7.9 ± 5.5   -1.0 ± 0.9 < 0.0001
Δ E/e' ratio -3.9 ± 3.4   -1.1 ± 0.9 < 0.0001

FC: functional class; NYHA: New York Heart Association; LAV ind: left atrial volume index; LVD: left ventricular diastole; LVS: left ventricular systole; LV: left ventricle; LVEF: left ventricular ejection fraction.

Figure 1 Example of left atrium (LA) reverse remodeling after successful atrial fibrillation ablation. 1a) LA volume index before ablation; 1b) LA volume index 12 months after ablation. 


Intraobserver variability for E wave velocity, e' wave velocity, and LA volume were 2.0%, 3.3%, and 2.3%, respectively. Interobserver variability for E wave velocity, e' wave velocity, and LA volume were 3.7%, 3.5% and 4.3%, respectively.


The main findings of this study were related to LV filling pressure and LA reverse remodeling. Using Doppler echocardiography, we showed that successful AF ablation reduces LA volume and improves LV filling pressure estimated by E/e' ratio.

Reverse remodeling of LA post-AF ablation

Volume and pressure overload are recognized as the main factors leading to the adaptive responses that occur in LA remodeling. This overload promotes distension of the LA and PVs, which generates rapid and disorganized electrical activity favoring AF occurrence3,4. The adaptive responses leading to this phenomenon are myocyte growth, hypertrophy, necrosis, alterations of fibrocollagenous connective tissue, and changes in the expression of cellular ion channels and atrial hormones, including atrial natriuretic peptide20,21. Furthermore, in the setting of LA volume overload and/or LA pressure overload, LA myocytes are more likely to depolarize, increasing vulnerability to AF22. After AF occurrence, the arrhythmia may be maintained by a remodeled substrate, but AF itself also promotes atrial remodeling ("AF begets AF")23. Thus, as previously hypothesized, the restoration of sinus rhythm leads to LA reverse remodeling after successful AF ablation, electrical cardioversion or cardiac surgery24-26. Beukema et al16 found that LA diameter decreased from the baseline significantly in patients with persistent sinus rhythm after ablation, and they also found that recurrent AF was associated with larger diameters. Verma et al27 reported similar results in LA diameter reduction in a series of patients who underwent extensive PV antrum ablation27. Recently, Machino-Ohtsuka et al28 reported a significant LA volume reverse remodeling after 12 months of successful AF ablation. Similar findings were demonstrated using cardiac magnetic resonance29. Our results are in agreement with these studies because a significant improvement in LA reverse remodeling was found in our successful ablation population, in which LAVind decreased from 30.2 ± 10.6 mL/m2 to 22.6 ± 1.1 mL/m2 (p < 0.001). We measured LA volume, which is more accurate than LA diameter, to evaluate reverse LA remodeling after AF treatment. LA diameter is measured in M-mode, using a single LA dimension and may, thus, underestimate LA size. On the other hand, the LA index volume is measured using biplane Simpson's rule (4- and 2-chamber views), which is more reliable. This method has been validated with computed tomography30 and magnetic resonance measurement31.

It is important to emphasize that LA reverse remodeling was also observed in patients with paroxysmal AF (21.8 ± 11.9 mL/m2 to 14.1 ± 5.5 mL/m2, p < 0.001). Although our series had only 18 patients with paroxysmal AF, this finding was consistent. Similarly, 49% of patients from the study by Beukema et al16 had paroxysmal AF, and these patients showed a reduction in LA diameter from 40.5 ± 4.4 to 37.5 ± 3.5 mm (p < 0.01). In the study by Tops et al32, 61% of patients had paroxysmal AF, but they did not compare this subgroup with persistent and long-standing persistent AF patients. These findings were also observed in the study by Reant et al33, which showed a reduction in longitudinal diameter from 59.7 ± 7.3 mm to 53.19 ± 7.7 mm six months after ablation in the subgroup of patients with paroxysmal AF.

Remodeling of the LA substrate appears to play an important role in the success rate of AF ablation, but the mechanism responsible for LA reverse remodeling after successful ablation is not clear yet. Our results support the findings reported by Reant et al33, who suggested that diastolic dysfunction may cause isolated AF by the combination of LA and PV stretch and enlargement, which results from LV end-diastolic pressure. One could argue that extensive ablation shrinks the left atrium, and that reverse remodeling would not be related to sinus rhythm restoration. However, in our series, reverse remodeling was not observed in patients with recurrent AF.

Improvement of left ventricle diastolic function

Diastolic dysfunction is a common cause of volume and/or pressure overload, which leads to LA remodeling and may further result in structural and electrophysiological heterogeneity, promoting a substrate for AF occurrence. Thus, it is not surprising that the restoration of sinus rhythm could also improve diastolic function. Sinus rhythm restoration after ablation results in LA reverse remodeling, but these studies have not noted a clear benefit in LV diastolic function. The lack of a clear benefit may be explained by the fact that although the LA volume index is a reliable method to evaluate abnormalities in LV diastolic loading34,35, this index is a measure of LA function. However, Hurrell et al36 showed that there is a very good correlation between the LA volume index and invasive LV diastolic loading36. The LA volume index has been used in different settings as a measure of diastolic function4,35,37-39. By incorporating other methods to estimate LV filling pressure, we were able to show its improvement after restoration and maintenance of sinus rhythm following AF ablation.

Although pulsed-wave Doppler analysis of the mitral valve inflow and PV flow are commonly used, these measurements may be influenced by preload and afterload9. This limitation is even more pronounced in patients with AF due to changes in LA filling and loss of LA contraction. In this situation, TDI imaging is the most accurate method to estimate LV filling pressure. In our study population, patients with non-successful AF ablation had a lower e' and higher E/e' ratio than patients with successful AF ablation, suggesting a relationship between elevated LV filling pressure and poor AF ablation outcome. Furthermore, there was a significant reduction in the E/e' ratio during follow-up in successful patients, suggesting that sinus rhythm restoration has a positive impact on LV filling pressure. The same findings were observed in patients with paroxysmal AF. Only a few studies have tried to assess the relationship between AF and ventricular diastolic filling patterns. Melek40 et al. reported the cardioversion effect on TDI parameters in persistent AF patients. They were not able to find any significant improvement on diastolic function after restoration of sinus rhythm with the exception of atrial function, but the follow-up period was very short. In contrast, some studies found that impaired diastolic filling was an independent predictor of late recurrence following cardioversion41 and ablation42.

Patients with pronounced ventricular filling impairment are at greater risk for AF. What is not clear is if AF can worsen LV diastolic function. During acute rapid AF, there are some mechanisms explaining the worsening of LV diastolic function, for example, loss on LA contraction, irregular LV filling, and rate and worse AV synchrony; long-standing AF data are still scarce. Some mechanistic insights came from the studies of Goette et al43,44, who showed in animal and human models that AF lead to down-regulation of the endothelial nitric oxide synthase and elevated asymmetric dimethylarginine, which are associated with vascular dysfunction and heart failure. They also showed a reduction in aldosterone levels after restoration of sinus rhythm.

There is lack of data showing improvement of diastolic function after successful AF ablation. Reant et al33 found that diastolic function improved significantly 12 months since the procedure, with an increase in lateral early diastolic peak velocity of 29% (p < 0.001) in paroxysmal AF and 46% (p < 0.05) in chronic AF patients. Cha et al45 reported a diastolic function improvement following successful AF ablation. Diastolic function was graded from 1 to 4 according to ASE guidelines46, however all patients included were in sinus rhythm at the time of their transthoracic echocardiograms. Our study included a large number of patients with persistent and permanent AF, so that 66% were not in sinus rhythm during echocardiographic measurements. Nevertheless, we suggest an association between successful AF ablation and estimated LV filling improvement.

Study limitations

Although we have shown an association between LA volume index reduction and improvements in LV filling pressure in patients with successful AF ablation, we acknowledge that this association may not be related just to ablation. LA reverse remodeling after successful AF ablation may result not only from sinus rhythm restoration but may also be a consequence of better left atrial-ventricular synchronism. Further prospective studies are necessary to confirm this hypothesis.

We did not perform seven-day ambulatory monitoring, and asymptomatic AF recurrences may have been missed. However, we investigated patients for asymptomatic AF recurrences during the first year of follow-up: ECG was recorded monthly, and Holter monitoring was done in the third, sixth, and twelfth month after ablation.

Finally, this was a non-randomized, single-arm study, and some echocardiography measurements that are thought to be a consequence of the ablation procedure may have been influenced by other factors. For example, after invasive procedures, some patients become more compliant with pharmacological treatment and exercise, and this may have altered the echocardiography measurements regardless of the ablation procedure.

Because this is the initial experience of a single private practice service, most patients referred for ablation were classified into persistent or long standing persistent AF, according to HRS 2007 consensus, making this study difficult to compare with other AF ablation studies, which have mostly paroxysmal AF patients.


AF ablation showed better results in patients with paroxysmal and persistent AF than long-standing persistent AF. When sinus rhythm was maintained consistently, there was an improvement in estimated LV filling pressure and LA reverse remodeling.

Author contributions

Conception and design of the research: Santos, SN; Henz, BD; Zanatta, AR; Barreto, JR; Leite, LR. Acquisition of data: Santos, SN; Henz, BD; Zanatta, AR; Barreto, JR; Loureiro, KB; Novakoski, C; Santos, MVN; Giuseppin, FF; Oliveira, EM; Leite, LR. Statistical analysis: Santos, SN; Leite, LR. Analysis and interpretation of the data: Santos, SN; Leite, LR. Writing of the manuscript: Santos, SN; Leite, LR. Critical revision of the manuscript for intellectual content: Santos, SN; Henz, BD; Leite, LR.

Sources of Funding

There were no external funding sources for this study.

Study Association

This study is not associated with any thesis or dissertation work.


Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40(9):1636-44. [ Links ]

Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47(12):2357-63. [ Links ]

Wyse DG, Gersh BJ. Atrial fibrillation: a perspective: thinking inside and outside the box. Circulation. 2004;109(25):3089-95. [ Links ]

Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90(12):1284-9. [ Links ]

Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol. 2003;91(6):780-4. [ Links ]

Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30(6):1527-33. [ Links ]

Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000;102(15):1788-94. [ Links ]

Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation. 1998;98(16):1644-50. [ Links ]

Sohn DW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr. 1999;12(11):927-31. [ Links ]

Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol. 2002;40(3):464-74. [ Links ]

Shah DC, Haissaguerre M, Jais P. Catheter ablation of pulmonary vein foci for atrial fibrillation: PV foci ablation for atrial fibrillation. Thorac Cardiovasc Surg. 1999;47 (Suppl 3):352-6. [ Links ]

Pappone C, Oreto G, Lamberti F, Vicedomini G, Loricchio ML, Shpun S, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation. 1999; 100(11):1203-8. [ Links ]

Packer DL, Asirvatham S, Munger TM. Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(12 Suppl):S296-309. [ Links ]

Hagens VE, Van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJ, et al. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm. 2005;2(1):19-24. [ Links ]

Fleck T, Wolf F, Bader T, Lehner R, Aigner C, Stix G, et al. Atrial function after ablation procedure in patients with chronic atrial fibrillation using steady-state free precession magnetic resonance imaging. Ann Thorac Surg. 2007;84(5):1600-4. [ Links ]

Beukema WP, Elvan A, Sie HT, Misier AR, Wellens HJ. Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size. Circulation. 2005;112(14):2089-95. [ Links ]

Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48(4):854-906. [ Links ]

Leite LR, Santos SN, Maia H, Henz BD, Giuseppin F, Oliverira A, et al. Luminal Esophageal Temperature Monitoring with a Deflectable Esophageal Temperature Probe and Intracardiac Echocardiography May Reduce Esophageal Injury During Atrial Fibrillation Ablation Procedures - Results of a Pilot Study. Circ Arrhythm Electrophysiol. 2011;4(2):149-56. [ Links ]

Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-63. [ Links ]

Nattel S. Electrophysiologic remodeling: are ion channels static players or dynamic movers? J Cardiovasc Electrophysiol. 1999;10(11):1553-6. [ Links ]

Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation. 1996; 94(11):2968-74. [ Links ]

Mary-Rabine L, Albert A, Pham TD, Hordof A, Fenoglio JJ Jr, Malm JR, et al. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res. 1983;52(2):188-99. [ Links ]

Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954-68. [ Links ]

Perea RJ, Tamborero D, Mont L, De Caralt TM, Ortiz JT, Berruezo A, et al. Left atrial contractility is preserved after successful circumferential pulmonary vein ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(4):374-9. [ Links ]

Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, Jr., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934-41. [ Links ]

Mattioli AV, Sansoni S, Lucchi GR, Mattioli G. Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function. Am J Cardiol. 2000;85(7):832-6. [ Links ]

Verma A, Kilicaslan F, Adams JR, Hao S, Beheiry S, Minor S, et al. Extensive ablation during pulmonary vein antrum isolation has no adverse impact on left atrial function: an echocardiography and cine computed tomography analysis. J Cardiovasc Electrophysiol. 2006;17(7):741-6. [ Links ]

Machino-Ohtsuka T, Seo Y, Ishizu T, Yanaka S, Nakajima H, Atsumi A, et al. Significant improvement of left atrial and left atrial appendage function after catheter ablation for persistent atrial fibrillation. Circ J. 2013;77(7):1695-704. [ Links ]

Muellerleile K, Groth M, Steven D, Hoffmann BA, Saring D, Radunski UK, et al. Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(7):762-7. [ Links ]

Kircher B, Abbott JA, Pau S, Gould RG, Himelman RB, Higgins CB, et al. Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine computed tomography. Am Heart J. 1991;121(3 Pt 1):864-71. [ Links ]

Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson. 2004;6(4):855-63. [ Links ]

Tops LF, Bax JJ, Zeppenfeld K, Jongbloed MR, van der Wall EE, Schalij MJ. Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size. Am J Cardiol. 2006;97(8):1220-2. [ Links ]

Reant P, Lafitte S, Jais P, Serri K, Weerasooriya R, Hocini M, et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation. 2005;112(19):2896-903. [ Links ]

Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio TA. Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). Am J Cardiol. 2006;97(1):83-9. [ Links ]

Lim TK, Ashrafian H, Dwivedi G, Collinson PO, Senior R. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure. Eur J Heart Fail. 2006;8(1):38-45. [ Links ]

Hurrell DG, Nishimura RA, Ilstrup DM, Appleton CP. Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1997;30(2):459-67. [ Links ]

Tsang TS, Barnes ME, Abhayaratna WP, Cha SS, Gersh BJ, Langins AP, et al. Effects of quinapril on left atrial structural remodeling and arterial stiffness. Am J Cardiol. 2006;97(6):916-20. [ Links ]

Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003;107(17):2207-12. [ Links ]

Hung MJ, Cherng WJ. Analysis of left atrial volume change rate for evaluation of left ventricular diastolic function. Echocardiography. 2004;21(7):593-601. [ Links ]

Melek M, Birdane A, Goktekin O, Ata N, Celik A, Kilit C, et al. The effect of successful electrical cardioversion on left ventricular diastolic function in patients with persistent atrial fibrillation: a tissue Doppler study. Echocardiography. 2007;24(1):34-9. [ Links ]

Caputo M, Urselli R, Capati E, Navarri R, Sinesi L, Furiozzi F, et al. Usefulness of left ventricular diastolic dysfunction assessed by pulsed tissue Doppler imaging as a predictor of atrial fibrillation recurrence after successful electrical cardioversion. Am J Cardiol. 2011;108(5):698-704. [ Links ]

Ejima K, Shoda M, Arai K, Suzuki A, Yagishita D, Yagishita Y, et al. Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation. Int J Cardiol. 2013;164(1):88-93. [ Links ]

Goette A, Hammwohner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, et al. The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol. 2012;154(2):141-6. [ Links ]

Goette A, Hoffmanns P, Enayati W, Meltendorf U, Geller JC, Klein HU. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol. 2001;88(8):906-9, A8. [ Links ]

Cha YM, Wokhlu A, Asirvatham SJ, Shen WK, Friedman PA, Munger TM, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4(5):724-32. [ Links ]

Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10(2):165-93. [ Links ]

Received: February 02, 2014; Revised: June 19, 2014; Accepted: July 31, 2014

Mailing Address: Simone Nascimento dos Santos, SMDB conjunto 16 lote 5 casa A, Lago Sul. Postal Code 71680-160. Brasília, DF - Brazil. Email:;

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.